Search Results
Typhonium Plus®
Natural Supplement for Cancer
|
|
Effective For:
|
Breast Cancer |
Colon Cancer |
Rectum Cancer |
Liver Cancer |
Prostate Cancer |
Leukemia |
Cervical Cancer |
Lung Cancer |
|
| Typhonium Plus Natural Supplement for Cancer |
Typhonium Plus – Alternative Cancer Treatment (Typhonium flagelliforme / Keladi Tikus extract)
As a natural supplement may help to combat cancer/tumor and stimulate anti body.
Typhonium Plus formula traditionally use for cancer/tumor patients to combat breast, colon, rectum, liver, prostate, leukemia, cervical cancer and lung cancer.
Cancer is not one specific disease. It is a process that can affect any organ of the body. A healthy human body consists of normal growing cells which carry out the life processes in a normal and orderly manner. A normal living cell can, for various unfortunate reasons, turn abnormal or cancerous. It multiplies in the body rapidly and excessively, forming a group of cells of uncontrollable growth resulting in a swelling. Then the abnormal cells break up and invade adjacent tissues and organs and destroy them. With each hectic, uncontrolled and disordered cell growth, the body’s energies are misused and wasted. If this continues unchecked, death can occur.
Typhonium flagelliforme / Keladi Tikus is a herbal plant grows in East Asia as traditional medicine to combat cancer.
How Does Typhonium Plus Affect Your Body?
Typhonium flagelliforme / Keladi Tikus extract and other herbs combine help in the detoxification of the blood system. Typhonium Plus contains ribosome in acting protein (RIP), anti oxidant, and anti curcumin. Together triggered cells may in turn produce mediators that stimulate and strengthen other cells of the immune system of the body to combat the cancerous cells. Since the growth of cancerous cells is reversible given the correct chemical stimulus and environment, this explanation is not far-fetched.
Typhonium Plus is a combination of selective herbs extract which in synergy strengthening works of Typhonium flagelliforme / Keladi Tikus
Typhonium Plus Registered POM TR 043 330 391 Indonesia Health Department
Suggested Usage:
Stadium I – II, take 1 capsule 2 times daily before meal.
Stadium III above, take 2 capsules 2 times daily before meal; or as directed by health care practitioner.
Composition:
Typhonium flagelliforme / Keladi Tikus 80%, Andrographis paniculata 10%, Curcuma zedoaria 10% (in extract form)
Storage: Store at room temperature & away from children.
Packing size: Packing with 20 capsules.
Attention:
- Two days after consuming Typhonium Plus, you may feel stomach problem, little diare, faeces turn black and body feel fatigue.
- Sometimes patient may vomit after consumption, if this symptoms happened stop taking the capsule ,when you feel better, you can continue taking the capsules but reduce the dosage or consult with your medical practitioner.
- Pregnant women should not take these capsules
What They said about Typhonium Plus: ** Testimonial **
Manufactured by: Global Bioscience, Jakarta, Indonesia
Distributed by: ISG – Inti Sumatera Global, Jakarta
We would love to hear from you if you have any comments or questions. Contact us at PO BOX 6172 JKUPL 14440 A, Indonesia or Mail to : cs@typhoniumplus.co.id.
Disclaimer: The statements and information upon this website have not necessarily been evaluated by the Food and Drug Administration. The product featured are not intended to diagnose, treat, cure or prevent any disease. Consumers should always consult their own medical practitioner(s) with any medical or health concerns before starting any new diet, product or supplement.
Disclaimer and Release of Liability
Our Main Principles
- We do not substitute medical doctors. We advise you to seek proper medical help.
- We advocate the use of natural herbal formula towards your healing.
- We do not guarantee that the natural herbal formula can cure you of your cancer/tumor, but experiences of others showed that the herbs brought great relief and healing.
- Healing can only come if you lead a healthy lifestyle, free of stress (physical and mental) and take proper food. Having peace of mind and to believe in God is just as important as taking herbs or the right medical treatment.
Friday, May 18th, 2012
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial. The phase I/II trial, co-led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G.
Posted in Uncategorized | No Comments »
Wednesday, May 2nd, 2012
Research led by St. Jude Children’s Research Hospital investigators suggests that safeguarding cell survival and maintaining a balanced immune system is just the start of the myeloid cell leukemia sequence 1 (MCL1) protein’s work…
Posted in Uncategorized | No Comments »
Thursday, April 26th, 2012
Researchers at the University of California-San Diego School of Medicine have shown that G protein-coupled receptor expression may predict the prognosis of patients with chronic lymphocytic leukemia. Their findings may identify new ways to treat such patients.
Posted in Uncategorized | No Comments »
Tuesday, April 17th, 2012
A new study describes a therapeutic approach to halting cancer progression by exploiting a previously unrecognized “addiction” of leukemia cells to specific signaling molecules…
Posted in Uncategorized | No Comments »
Tuesday, April 17th, 2012
A new study describes a therapeutic approach to halting cancer progression by exploiting a previously unrecognized “addiction” of leukemia cells to specific signaling molecules…
Posted in Uncategorized | No Comments »
Tuesday, April 17th, 2012
Through a groundbreaking new gene sequencing technology, researchers have demonstrated that the gene FLT3 is a valid therapeutic target in Acute Myeloid Leukemia, AML, one of the most common types of leukemia.
Posted in Uncategorized | No Comments »
Monday, April 16th, 2012
An international study published in the April 12 issue of the New England Journal of Medicine reports that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to achieve clinical remission following their induction therapy of intense chemotherapy…
Posted in Uncategorized | No Comments »
Monday, April 16th, 2012
An international study published in the April 12 issue of the New England Journal of Medicine reports that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to achieve clinical remission following their induction therapy of intense chemotherapy…
Posted in Uncategorized | No Comments »
Monday, April 16th, 2012
An international study published in the April 12 issue of the New England Journal of Medicine reports that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to achieve clinical remission following their induction therapy of intense chemotherapy…
Posted in Uncategorized | No Comments »
Thursday, April 12th, 2012
An international study found that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to attain clinical remission after the initial weeks of intense chemotherapy known as induction therapy…
Posted in Uncategorized | No Comments »

Bing.com: This page is your resource for information on all types of leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative diseases.
Source URL powered by Bing:
http://www.leukemia.org/

Bing.com: Get the facts on leukemia (cancer of the bone marrow, blood) causes, symptoms, signs, types (hairy cell, chronic/acute lymphocytic or myeloid), research, treatment ...
Source URL powered by Bing:
http://www.medicinenet.com/leukemia/article.htm